{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:56:24Z","timestamp":1765886184341,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Heart transplantation (HTx) for patients with \u201cgiant cell myocarditis\u201d (GCM) or \u201ccardiac sarcoidosis\u201d (CS) is still controversial. However, no single center has accumulated enough experience to investigate post-HTx outcome. The primary aim of this systematic review is to identify, appraise, and synthesize existing literature investigating whether patients who have undergone HTx because of GCM or CS have worse outcomes as compared with patients transplanted because of other etiologies. A systematic and comprehensive search will be performed using PubMed, Scopus, Web of Science, EMBASE, and Google Scholar, for studies published up to December 2019. Observational and interventional population-based studies will be eligible for inclusion. The quality of observational studies will be assessed using the Newcastle\u2013Ottawa scale, while the interventional studies will be assessed using the Cochrane Effective Practice Organization of Care tool. The collected evidence will be narratively synthesized; in addition, we will perform a meta-analysis to pool estimates from studies considered to be homogenous. Reporting of the systematic review and meta-analysis will be in accordance with the Meta-analysis of Observational Studies in Epidemiology Preferred Reporting Items for Systematic reviews and Meta-Analysis guidelines. To our knowledge, this will be the first synthesis of outcomes, including survival, acute cellular rejection, and disease recurrence, in patients with either GCM or CS treated with HTx. Reviewing the suitability of HTx in this population and highlighting areas for further research will benefit both patients and healthcare providers. Trial registration: CRD42019140574.<\/jats:p>","DOI":"10.1007\/s10741-020-09919-x","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T03:02:45Z","timestamp":1578970965000},"page":"481-485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Inflammatory cardiomyopathies: short- and long-term outcomes after heart transplantation\u2014a protocol for a systematic review and meta-analysis"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8287-2448","authenticated-orcid":false,"given":"Emanuele","family":"Bobbio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Lingbrant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bright I","family":"Nwaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Hessman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jukka","family":"Lehtonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristjan","family":"Karason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Entela","family":"Bollano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"issue":"7","key":"9919_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1161\/CIRCRESAHA.117.310221","volume":"121","author":"BH Trachtenberg","year":"2017","unstructured":"Trachtenberg BH, Hare JM (2017) Inflammatory cardiomyopathic syndromes. Circ Res 121(7):803\u2013818. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310221","journal-title":"Circ Res"},{"issue":"1","key":"9919_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.chest.2016.08.1457","volume":"151","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Lower EE, Li HP, Costea A, Attari M, Baughman RP (2017) Cardiac sarcoidosis: the impact of age and implanted devices on survival. Chest 151(1):139\u2013148. https:\/\/doi.org\/10.1016\/j.chest.2016.08.1457","journal-title":"Chest"},{"issue":"6","key":"9919_CR3","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","volume":"58","author":"KJ Silverman","year":"1978","unstructured":"Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58(6):1204\u20131211","journal-title":"Circulation"},{"issue":"10 Pt 1","key":"9919_CR4","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","volume":"164","author":"Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Jr., Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R, Case Control Etiologic Study of Sarcoidosis research g","year":"2001","unstructured":"Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Jr., Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R, Case Control Etiologic Study of Sarcoidosis research g (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164(10 Pt 1):1885\u20131889. https:\/\/doi.org\/10.1164\/ajrccm.164.10.2104046","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"9919_CR5","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","volume":"131","author":"R Kandolin","year":"2015","unstructured":"Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, Kaikkonen K, Tuohinen S, Haataja P, Kerola T, Kokkonen J, Pelkonen M, Pietila-Effati P, Utrianen S, Kupari M (2015) Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation 131(7):624\u2013632. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.011522","journal-title":"Circulation"},{"issue":"5","key":"9919_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jjcc.2012.07.013","volume":"60","author":"H Akashi","year":"2012","unstructured":"Akashi H, Kato TS, Takayama H, Naka Y, Farr M, Mancini D, Schulze PC (2012) Outcome of patients with cardiac sarcoidosis undergoing cardiac transplantation--single-center retrospective analysis. J Cardiol 60(5):407\u2013410","journal-title":"J Cardiol"},{"issue":"12","key":"9919_CR7","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/S0002-9149(02)02368-8","volume":"89","author":"AS Donsky","year":"2002","unstructured":"Donsky AS, Escobar J, Capehart J, Roberts WC (2002) Heart transplantation for undiagnosed cardiac sarcoidosis. Am J Cardiol 89(12):1447\u20131450","journal-title":"Am J Cardiol"},{"issue":"7","key":"9919_CR8","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.healun.2007.05.006","volume":"26","author":"AR Zaidi","year":"2007","unstructured":"Zaidi AR, Zaidi A, Vaitkus PT (2007) Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J Heart Lung Transplant 26(7):714\u2013717","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"9919_CR9","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1097\/TP.0000000000000673","volume":"99","author":"A Banga","year":"2015","unstructured":"Banga A, Sahoo D, Lane CR, Farver CF, Budev MM (2015) Disease recurrence and acute cellular rejection episodes during the first year after lung transplantation among patients with sarcoidosis. Transplantation 99(9):1940\u20131945. https:\/\/doi.org\/10.1097\/TP.0000000000000673","journal-title":"Transplantation"},{"issue":"9","key":"9919_CR10","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.echo.2016.06.001","volume":"29","author":"E Joyce","year":"2016","unstructured":"Joyce E, Kamperidis V, Ninaber MK, Katsanos S, Debonnaire P, Schalij MJ, Taube C, Bax JJ, Delgado V, Ajmone Marsan N (2016) Prevalence and correlates of early right ventricular dysfunction in sarcoidosis and its association with outcome. J Am Soc Echocardiogr 29(9):871\u2013878. https:\/\/doi.org\/10.1016\/j.echo.2016.06.001","journal-title":"J Am Soc Echocardiogr"},{"issue":"7","key":"9919_CR11","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1016\/S0828-282X(10)70424-4","volume":"26","author":"A Luk","year":"2010","unstructured":"Luk A, Lee A, Ahn E, Soor GS, Ross HJ, Butany J (2010) Cardiac sarcoidosis: recurrent disease in a heart transplant patient following pulmonary tuberculosis infection. The Canadian journal of cardiology 26(7):e273\u2013e275","journal-title":"The Canadian journal of cardiology"},{"issue":"11","key":"9919_CR12","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.healun.2005.02.016","volume":"24","author":"JE Yager","year":"2005","unstructured":"Yager JE, Hernandez AF, Steenbergen C, Persing B, Russell SD, Milano C, Felker GM (2005) Recurrence of cardiac sarcoidosis in a heart transplant recipient. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 24(11):1988\u20131990. https:\/\/doi.org\/10.1016\/j.healun.2005.02.016","journal-title":"The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation"},{"issue":"2 Pt 1","key":"9919_CR13","first-page":"367","volume":"11","author":"AA Oni","year":"1992","unstructured":"Oni AA, Hershberger RE, Norman DJ, Ray J, Hovaguimian H, Cobanoglu AM, Hosenpud JD (1992) Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 11(2 Pt 1):367\u2013369","journal-title":"The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation"},{"issue":"2","key":"9919_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s12350-013-9677-3","volume":"20","author":"M Osborne","year":"2013","unstructured":"Osborne M, Kolli S, Padera RF, Naya M, Lewis E, Dorbala S, Di Carli MF, Blankstein R (2013) Use of multimodality imaging to diagnose cardiac sarcoidosis as well as identify recurrence following heart transplantation. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 20(2):310\u2013312. https:\/\/doi.org\/10.1007\/s12350-013-9677-3","journal-title":"Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology"},{"issue":"6","key":"9919_CR15","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/j.transproceed.2013.02.116","volume":"45","author":"D Perkel","year":"2013","unstructured":"Perkel D, Czer LS, Morrissey RP, Ruzza A, Rafiei M, Awad M, Patel J, Kobashigawa JA (2013) Heart transplantation for end-stage heart failure due to cardiac sarcoidosis. Transplant Proc 45(6):2384\u20132386","journal-title":"Transplant Proc"},{"issue":"8","key":"9919_CR16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jfma.2011.12.010","volume":"112","author":"JH Tsai","year":"2013","unstructured":"Tsai JH, Chou NK, Wang SS, Shun CT (2013) Isolated cardiac sarcoidosis: case experience in heart transplantation. Journal of the Formosan Medical Association = Taiwan yi zhi 112(8):499\u2013500. https:\/\/doi.org\/10.1016\/j.jfma.2011.12.010","journal-title":"Journal of the Formosan Medical Association = Taiwan yi zhi"},{"issue":"26","key":"9919_CR17","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1056\/nejm199706263362603","volume":"336","author":"LT Cooper Jr","year":"1997","unstructured":"Cooper LT Jr, Berry GJ, Shabetai R (1997) Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter giant cell myocarditis study group investigators. N Engl J Med 336(26):1860\u20131866. https:\/\/doi.org\/10.1056\/nejm199706263362603","journal-title":"N Engl J Med"},{"issue":"2","key":"9919_CR18","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S0735-1097(02)02715-8","volume":"41","author":"Y Okura","year":"2003","unstructured":"Okura Y, Dec GW, Hare JM, Kodama M, Berry GJ, Tazelaar HD, Bailey KR, Cooper LT (2003) A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol 41(2):322\u2013329","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"9919_CR19","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.amjcard.2008.07.041","volume":"102","author":"LT Cooper Jr","year":"2008","unstructured":"Cooper LT Jr, Hare JM, Tazelaar HD, Edwards WD, Starling RC, Deng MC, Menon S, Mullen GM, Jaski B, Bailey KR, Cunningham MW, Dec GW (2008) Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol 102(11):1535\u20131539","journal-title":"Am J Cardiol"},{"issue":"12","key":"9919_CR20","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.amjcard.2015.03.023","volume":"115","author":"JJ Maleszewski","year":"2015","unstructured":"Maleszewski JJ, Orellana VM, Hodge DO, Kuhl U, Schultheiss HP, Cooper LT (2015) Long-term risk of recurrence, morbidity and mortality in giant cell myocarditis. Am J Cardiol 115(12):1733\u20131738. https:\/\/doi.org\/10.1016\/j.amjcard.2015.03.023","journal-title":"Am J Cardiol"},{"key":"9919_CR21","doi-asserted-by":"crossref","unstructured":"Kandolin R, Lehtonen J, Kupari M (2013) Cardiac sarcoidosis is a slowly progressive cardiomyopathy. European heart journal 1):672-673","DOI":"10.1093\/eurheartj\/eht309.3770"},{"issue":"6","key":"9919_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S1053-2498(02)00379-0","volume":"21","author":"RA Davies","year":"2002","unstructured":"Davies RA, Veinot JP, Smith S, Struthers C, Hendry P, Masters R (2002) Giant cell myocarditis: clinical presentation, bridge to transplantation with mechanical circulatory support, and long-term outcome. J Heart Lung Transplant 21(6):674\u2013679","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"9919_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1053-2498(00)00314-4","volume":"20","author":"RL Scott","year":"2001","unstructured":"Scott RL, Ratliff NB, Starling RC, Young JB (2001) Recurrence of giant cell myocarditis in cardiac allograft. J Heart Lung Transplant 20(3):375\u2013380","journal-title":"J Heart Lung Transplant"},{"key":"9919_CR24","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"350","author":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, Group P-P","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, Group P-P (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 350:g7647. https:\/\/doi.org\/10.1136\/bmj.g7647","journal-title":"BMJ"},{"issue":"15","key":"9919_CR25","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008\u20132012","journal-title":"JAMA"},{"key":"9919_CR26","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700. https:\/\/doi.org\/10.1136\/bmj.b2700","journal-title":"BMJ"},{"issue":"11","key":"9919_CR27","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539\u20131558. https:\/\/doi.org\/10.1002\/sim.1186","journal-title":"Stat Med"},{"issue":"4","key":"9919_CR28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64(4):401\u2013406. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.07.015","journal-title":"J Clin Epidemiol"},{"issue":"7124","key":"9919_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/bmj.316.7124.61","volume":"316","author":"M Egger","year":"1998","unstructured":"Egger M, Smith GD (1998) Bias in location and selection of studies. BMJ 316(7124):61\u201366","journal-title":"BMJ"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-09919-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-020-09919-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-09919-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T21:13:43Z","timestamp":1610572423000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-020-09919-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["9919"],"URL":"https:\/\/doi.org\/10.1007\/s10741-020-09919-x","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"type":"print","value":"1382-4147"},{"type":"electronic","value":"1573-7322"}],"subject":[],"published":{"date-parts":[[2020,1,14]]},"assertion":[{"value":"14 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}